Beilu Pharma
3000167.612.69% ( -0.21 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Beilu Pharma(300016) the Revenue is 320.37 M (+13.33%);the EBIT is 50.4 M (+70.69%);the EPS is 0.08 (+166.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.32B13.33%
----
----
EBIT
0.05B70.69%
----
----
EPS
0.08166.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf